Company Overview and News
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Wells Fargo (WFC), Schlumberger (SLB) and Biogen (BIIB). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
WFCNP STZ.B TXN NEP PBOWP PBOWN BIIB ICE WFC SLB UNP WLL PBI STZ PBI-B ITW SLB
As per North Dakota’s oil regulator, the state’s daily crude output rose 3.4% in July after edging down 1.6% in the previous month. The North Dakota Department of Mineral Resources’ (‘DMR’) latest data said that oil production in July averaged a record 1,269,366 barrels a day, up 42,046 barrels a day from June. To put this in perspective, oil supplies from the state of North Dakota is now at par with the struggling OPEC producer Venezuela.
ENBBF WLL PSX CTLR MALRY ENB MPC MIN ENB ETP OAS EBBNF CLR MALRF
Editor's note: Seeking Alpha is proud to welcome Tigron Park Energy as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more »
PACQU ECA WLL NDRO SM WHZT WHZ PACQ
2018-08-30 sec.gov - 3
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
Whiting Petroleum (WLL) has been on a tear in 2018, soaring by over $20 per share year-to-date. Even so since mid-May, it has leveled off and remained stagnant, even though management has upped its production guidance for 2018 by 500,000 barrels while reducing CapEx per well by $400,000.
Chicago, IL – August 23, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Zynga (ZNGA - Free Report) , Disney (DIS - Free Report) and 21st Century Fox (FOXA - Free Report) .
SOJA HD SO STZ.B WLL CTLR STZ DLTR ZNGA ETP OAS 7018 CME SRE CLR TAST
Chicago, IL – August 23, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Apple (AAPL - Free Report) , Alphabet (GOOGL - Free Report) , Tesla (TSLA - Free Report) , Xilinx (XLNX - Free Report) and NetApp (NTAP - Free Report) .
SOJA XLNX HD SO STZ.B WLL CTLR STZ DLTR BRK.A ETP OAS 7018 CME GOOGL SRE AAPL NTAP CLR TAST
Chicago, IL – August 23, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Energy Transfer Partners L.P. (ETP - Free Report) , Phillips 66 (PSX - Free Report) , Oasis Petroleum Inc. (OAS - Free Report) , Whiting Petroleum Corp.
SOJA HD STZ.B TXN PSX MALRY MIN DLTR CME TAST SO JELD WLL CTLR STZ ETP OAS 7018 SRE CLR MALRF
2018-07-30 - Asif
Overview Whiting Petroleum is an independent oil and gas company engaged in development, production, acquisition and exploration activities primarily in the Rocky Mountains region of the United States. The company's current operations and capital programs are focused on organic drilling opportunities and on the development of previously acquired properties, specifically on projects that the company believe provide the greatest potential for repeatable success and production growth, while selectively pursuing acquisitions that complement its existing core properties. During 2017, the company focused its drilling activity on projects that provide the highest rate of return, while closely aligning its capital spending with cash flows generated from operations. During 2018, the company continue to focus on high-return projects in its asset portfolio that will add production and reserves while generating free cash flows from operations. In addition, the company continually evalu...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to WLL / Whiting Petroleum Corp. on message board site Silicon Investor.
as of ET